Diffuse bone metastasis with hematologic disorders from gastric cancer: clinicopathological features and prognosis.
Tsuyoshi Etoh(Oita University), H Tomoda(National Hospital Organization Kyushu Cancer Center), Yohan Seo(Daegu-Gyeongbuk Medical Innovation Foundation), Akinobu Taketomi(Hokkaido University), Hideo Baba(Kaketsuken (Japan)), Shunji Kohnoe(Fukuoka Dental College), Tsubasa Fukuda(National Hospital Organization Kyushu Cancer Center), Hiroaki Nakashima(Nagoya University)
Cited by 40
Related Papers
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
|Journal of Clinical Oncology|2013|632
Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer
|British journal of surgery|2018|401
Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses
|Nature Medicine|2018|317
Interleukin‐6/<scp>STAT</scp>3 signaling as a promising target to improve the efficacy of cancer immunotherapy
|Cancer Science|2017|295
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition
|Nature Medicine|2018|282